PDE7B and B-cell chronic lymphocytic leukemia: In hematological malignancies, primary chronic lymphocytic leukemia patient samples were found to have PDE7B overexpression and noted to be sensitive to PDE7 inhibition in a cAMP‐dependent manner [38].